Doxycycline has anti-angiogenic properties and can inhibit matrix metalloproteinase (MMPs) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) signaling, which are important in the development and progression of cancer [40,41,42]. This evidence concerns the gene NFKB1 and cancer.